Humatica advises the Riverside Company on their recent investment in Alter Pharma

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma

Related News

Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023
14 Apr., 2025 By Humatica

Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023

Humatica, the leading specialist advisor to private equity firms on organizational effectiveness, is proud to announce that it has been named Value Creation Adviser of…

Read more arrowicon
Humatica Wins Actum’s Value Creation Award for a Second Time
26 März, 2025 By Humatica

Humatica Wins Actum’s Value Creation Award for a Second Time

Humatica, the specialist advisor to private equity firms on organizational effectiveness, has been awarded Actum’s Value Creation Award in the People & Organizational Strategy category—for…

Read more arrowicon
Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb., 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon